Signup Crypto ETF Stocks News

ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add neffy® ( Epinephrine Nasal Spray ) to National Formularies, Further Expanding Coverage for Patients

Approximately five months after launch, the inclusion of neffy on these three additional formularies has expanded access to half of all patients and caregivers managing Type 1 allergic reactions, bringing the total number of formulary platforms covering neffy to ...

Source: www.globenewswire.com
February 21, 2025 | 00:02:00
Category: News

Franklin Templeton Launches EZPZ ETF for Weighted Bitcoin, Ethereum Exposure

Franklin Templeton's newest crypto product, listed on the Cboe BZX exchange, offers investors both Bitcoin and Ethereum exposure.

Source: decrypt.co
February 21, 2025 | 00:05:26
Category: News

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX - ESSA Pharma ( NASDAQ:EPIX )

NEW YORK, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ESSA Pharma Inc. EPIX between December 12, 2023 and October 31, 2024, inclusive ( the "Class Period" ) , of the important March 25, 2025 lead plaintiff ...

Source: www.benzinga.com
February 21, 2025 | 00:25:00
Category: News

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN - Regeneron Pharmaceuticals ( NASDAQ:REGN )

NEW YORK, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. REGN between November 2, 2023 and October 30, 2024, both dates inclusive ( the "Class Period" ) , of the important March ...

Source: www.benzinga.com
February 21, 2025 | 00:26:14
Category: News

ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA - Bioage Labs ( NASDAQ:BIOA )

NEW YORK, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc.

Source: www.benzinga.com
February 21, 2025 | 00:28:56
Category: News

Centerra Gold Announces Quarterly Dividend of C$0.07 per Common Share - Centerra Gold ( NYSE:CGAU )

TORONTO, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- Centerra Gold Inc. ( "Centerra" or the "Company" ) CG CGAU announced today that its Board of Directors has approved a quarterly dividend of C$0.07 per common share - approximately C$14.7 million or US$10.2 million in aggregate.

Source: www.benzinga.com
February 20, 2025 | 22:02:32
Category: News

MercadoLibre Hits New Heights

Here's our initial take on MercadoLibre's ( NASDAQ: MELI ) fourth-quarter financial report.Investors couldn't have been happier with the results that MercadoLibre posted to finish 2024. Overall gains in revenue and profit in the fourth quarter were quite a bit better than expected, particularly ...

Source: www.fool.com
February 20, 2025 | 22:02:51
Category: News

Alarum Technologies, Inc. Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against ALAR - Alarum Technologies ( NASDAQ:ALAR )

SAN DIEGO, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons or entities who purchased or otherwise acquired Alarum Technologies Ltd. ALAR securities between March 14, 2024 and August 26, 2024.

Source: www.benzinga.com
February 20, 2025 | 22:08:52
Category: News

Monster Beverage to Report Financial Results for 2024 Fourth Quarter on February 27, 2025

Company to Conduct Conference Call at 2 p.m. Pacific Time Company to Conduct Conference Call at 2 p.m. Pacific Time ...

Source: www.globenewswire.com
February 20, 2025 | 22:10:00
Category: News

Monster Beverage to Report Financial Results for 2024 Fourth Quarter on February 27, 2025 - Monster Beverage ( NASDAQ:MNST )

CORONA, Calif., Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- Monster Beverage Corporation MNST announced today that results for its fourth quarter ended December 31, 2024, will be reported on Thursday, February 27, 2025, after the close of the market.

Source: www.benzinga.com
February 20, 2025 | 22:10:19
Category: News

© Natavest 2025 - 2026